Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTAI: Roxadustat vs rHuEPO on Iron Absorption in Anemia of CKD
NCT04655027Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by AstraZeneca. Started Feb 2021; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04655027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655027.